Product NDC: | 55253-071 |
Proprietary Name: | fentanyl citrate |
Non Proprietary Name: | fentanyl citrate |
Active Ingredient(s): | 400 ug/1 & nbsp; fentanyl citrate |
Administration Route(s): | TRANSMUCOSAL |
Dosage Form(s): | LOZENGE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55253-071 |
Labeler Name: | CIMA Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020747 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20060906 |
Package NDC: | 55253-071-30 |
Package Description: | 10 BLISTER PACK in 1 CARTON (55253-071-30) > 3 LOZENGE in 1 BLISTER PACK (55253-071-01) |
NDC Code | 55253-071-30 |
Proprietary Name | fentanyl citrate |
Package Description | 10 BLISTER PACK in 1 CARTON (55253-071-30) > 3 LOZENGE in 1 BLISTER PACK (55253-071-01) |
Product NDC | 55253-071 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fentanyl citrate |
Dosage Form Name | LOZENGE |
Route Name | TRANSMUCOSAL |
Start Marketing Date | 20060906 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | CIMA Laboratories, Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 400 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |